ancillary study

DRUG2 trials

Sponsors

Actelion, Assistance Publique - Hôpitaux de Paris

Conditions

Antibiotic Resistant StrainGlioblastomaTransmission, Close-Contact

Phase 1

Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma

TerminatedNCT01499251

ActelionGlioblastoma

Start: 2012-01-31End: 2016-04-30Target: 75Updated: 2016-05-05

Unknown Phase

Dynamics of AMR Spread, Persistence and Evolution Between Humans, Animals and Their Environment

Not yet recruitingNCT06262009

Assistance Publique - Hôpitaux de ParisAntibiotic Resistant Strain, Transmission, Close-Contact

Start: 2024-09-30End: 2027-03-31Target: 525Updated: 2024-02-15

Related Papers

Results of a phase I trial to assess the safety of macitentan in combination with temozolomide for the treatment of recurrent glioblastoma

Neuro-Oncology Advances2021-01-015 citations